AIBD

Constipation-related straining may be the cause of the lesion. How would you proceed?

Domperidone is better tolerated by some patients than metoclopramide. Before a switch, however, this test must be performed.

The 9-year-old was admitted after 1 day of symptoms; he had no fever, diarrhea, constipation, dysuria, or rash. More details here. What's your diagnosis?

Potential for infection is everywhere for patients with alcoholic cirrhosis.

Eosinophilic esophagitis is often misdiagnosed as gastroesophageal reflux disease but does not respond to acid suppression therapy. Here, a close-to-textbook case.

See if the results of this 62-year-old woman's colonoscopy help you identify the source of her abdominal pain.

Which of the following extraintestinal manifestations of inflammatory bowel disease often parallels disease activity?

These presenting symptoms began after a near syncopal episode. The patient has no significant medical or surgical history. More details, here.

The types of digestive disorders are many, and the symptoms vary widely. This week's photo quiz offers a variety of presentations to test your diagnostic acumen.

Here’s an opportunity for primary care to have a major impact on patients with a specialty-treated disease. Specialists will never boost vaccination rates to where they need to be. It’s just not what they do.

All patients with inflammatory bowel disease are at risk for anemia at any stage of their illness. In the past few years, there has been been increasing acceptance of the safety, efficacy, and speed of correcting deficiency with intravenous iron. Here: the pros and cons of oral vs IV supplementation.

These data suggest it may be worth a try-before moving on to potentially more dangerous drugs.

Fourteen state legislatures have passed legislation mandating that retail stores provide access to employee bathrooms for individuals with ulcerative colitis and Crohn disease and other medical needs.

Results are in on the maintenance phase of the TAXIT trial that employed infliXImab to treat patients with Crohn Disease and ulcerative colitis. Details here.

It's easy to mistake other serious gastrointestinal problems for inflammatory bowel disease. Here: clinical pearls that can help you recognize the IBD mimics.

This first report of effectiveness in a single case study should prompt additional research and placebo-controlled trials.

In case primary care physicians need another reason to pay attention to the overuse of antibiotics for nonbacterial illnesses.

Patients may be intimidated by their gastroenterologists, so it’ll probably fall on primary care to field them.

The Affordable Care Act comes none too soon for some of these patients.

And most have received treatments aimed at modifying immune system responses to control their disease.

A 72-year-old woman presents to the ED with fatigue, weakness, and palpitations. Her potassium level is 6.1 mEq/L, with a serum creatinine level of 1.9 mg/dL. What is the problem?

Fundic gland polyps are the most common form of gastric polyps. Giant FGPs, however, are extremely rare.

A new study validates online delivery as an effective means of promoting dietary adherence in celiac disease, and this method may prove effective across diets for patients with obesity, metabolic syndrome, and diabetes.

The goals of therapy for patients with inflammatory bowel disorder include inducing and maintaining a steroid-free remission, preventing and treating the complications of the disease, minimizing treatment toxicity, achieving mucosal healing, and enhancing quality of life.

New drugs are needed because a significant fraction of patients reach the end of the line with existing therapies.

All patients with IBD should receive aggressive ongoing assessment of their inflammatory state and its response to immunomodulators, anti-TNF drugs, and other agents.

A purely dichotomous understanding of whether to start treatment for patients who have IBD with anti-TNF agents is becoming an outdated view.

Even the most experienced and skilled gastroenterologists in the country are struggling to make science-based decisions in this area.

These agents remain the mainstay of therapy for the majority of patients with the disease.